Form 8-K/A - Current report: [Amend]
SEC Accession No. 0000950170-23-047925
Filing Date
2023-09-13
Accepted
2023-09-13 16:06:28
Documents
12
Period of Report
2023-08-18
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Document Format Files

Seq Description Document Type Size
1 8-K/A grph-20230818.htm   iXBRL 8-K/A 49770
  Complete submission text file 0000950170-23-047925.txt   176287

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT grph-20230818_pre.xml EX-101.PRE 10603
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT grph-20230818_lab.xml EX-101.LAB 14422
4 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT grph-20230818.xsd EX-101.SCH 2466
6 EXTRACTED XBRL INSTANCE DOCUMENT grph-20230818_htm.xml XML 5562
Mailing Address 201 HASKINS WAY, SUITE 210 SOUTH SAN FRANCISCO CA 94080
Business Address 201 HASKINS WAY, SUITE 210 SOUTH SAN FRANCISCO CA 94080 (650) 484-0886
Graphite Bio, Inc. (Filer) CIK: 0001815776 (see all company filings)

EIN.: 844867570 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K/A | Act: 34 | File No.: 001-40532 | Film No.: 231252754
SIC: 2836 Biological Products, (No Diagnostic Substances)